This site is intended for healthcare professionals only

Contraceptives linked to cancer

Written by: | Published:

Contraceptives linked to cancer Contraceptives linked to cancer

About 9400 brain tumours were diagnosed in 2011. Astrocytoma – a type of cancer called a glioma – is the most common, accounting for 34% of cases. Approximately 80% of astrocytomas are an aggressive subtype called glioblastoma multiforme. Research has suggested that long-term users of hormonal contraceptives are nearly twice as likely to develop gliomas as non-users.

Epidemiological studies reported either no link between contraceptive use and glioma or a weak protective effect in women. However, these studies enrolled only post-menopausal women or small numbers of premenopausal women. The new study examines the link in younger women.


Please login or register to read the rest of the article and to have access to downloads and comments.


What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.